Peptide profile
AOD-9604
HGH fragment for lipolysis stimulation
Compare AOD-9604 with other peptides →Summary
A piece of a growth helper that burns fat in certain spots.
- Typical dose
- 250-500mcg Twice daily
- Route
- Subcutaneous
- Cycle length
- 30-60 days
- Evidence
- Anecdotal
Mechanism
How it works
AOD-9604 is like a scalpel instead of a sledgehammer — it targets fat cells specifically without affecting other HGH pathways.
Modified fragment of human growth hormone (amino acids 177-191) that retains lipolytic activity while eliminating IGF-1 effects.
Reported in research
Benefits
- Helps your body break down fat
- Stops your body from storing new fat
- Does not mess with your blood sugar
Context, not a prescription
Dosing
- Typical range
- 250-500mcg Twice daily (Subcutaneous)
- Cycle length
- 30-60 days
Safety
Side effects & contraindications
Possible side effects
- Injection site pain
- Mild nausea
- Temporary fatigue
- Headache
- Dizziness
- Flushing
Contraindications
- Pregnancy or breastfeeding
- Severe diabetes
- Known hypersensitivity
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
You slowly lose fat, keep your muscle, and your blood sugar stays normal.
How it works
AOD-9604 is like a small knife, not a big hammer. It aims at fat cells only and leaves the rest alone.
It grabs onto special spots on fat cells. This switches on a tool that breaks down fat.
What to expect
You can see fat loss in about 4-6 weeks.
- Weeks 1-2: Your body starts moving fat around.
- Weeks 4-6: You slowly lose more fat.
- Weeks 8-12: You see the most fat burning.
Good to know
- Start with a smaller dose (250mcg)
- Take breaks between uses
- Keep an eye on your blood sugar
Staying safe
- Sore spot where you got the shot
- Feeling a little sick to your stomach
- Feeling tired for a short time
Avoid if you have:
- If you are pregnant or feeding a baby
- If you have very bad diabetes
- If your body reacts badly to it
Mechanism of action
Modified fragment of human growth hormone (amino acids 177-191) that retains lipolytic activity while eliminating IGF-1 effects.
Binds to beta-adrenergic receptors on adipocytes to activate hormone-sensitive lipase.
Pharmacodynamics
Fat loss effects visible by 4-6 weeks.
Progressive fat reduction, preserved lean mass, no blood sugar impact.
Timeline
- Weeks 1-2: Initial fat mobilization.
- Weeks 4-6: Progressive fat reduction.
- Weeks 8-12: Maximum lipolytic effect.
Comparisons
- AOD-9604 — effectiveness Limited, safety Emerging, cost $$, Medium to use
- Semaglutide — effectiveness Very High, safety Good, cost $$$, Easy to use
Adverse effects
Common:
- Injection site pain
- Mild nausea
- Temporary fatigue
Rare:
- Headache
- Dizziness
- Flushing
Contraindications & risk mitigation
Contraindicated in:
- Pregnancy or breastfeeding
- Severe diabetes
- Known hypersensitivity
- Start with lower dose (250mcg)
- Cycle with breaks
- Monitor blood glucose
Qué hace
Pierdes grasa lentamente, mantienes tu músculo y tu azúcar en sangre se mantiene normal.
Cómo funciona
AOD-9604 es como un cuchillo pequeño, no un martillo grande. Apunta solo a las células grasas y deja el resto intacto.
Se une a puntos especiales en las células grasas. Esto activa una herramienta que descompone la grasa.
Qué esperar
Puedes ver la pérdida de grasa en unas 4-6 semanas.
- Semanas 1-2: Tu cuerpo comienza a mover la grasa.
- Semanas 4-6: Pierdes más grasa lentamente.
- Semanas 8-12: Observas la mayor quema de grasa.
Bueno saber
- Comenzar con una dosis menor (250 mcg)
- Tomar descansos entre los usos
- Vigilar tu azúcar en sangre
Manteniéndose seguro
- Zona dolorida donde te aplicaste la inyección
- Sentir un poco de náuseas
- Sentirse cansado por un corto tiempo
Evitar si tienes:
- Si estás embarazada o dando el pecho
- Si tienes diabetes muy grave
- Si tu cuerpo reacciona mal al producto
Mecanismo de acción
Fragmento modificado de la hormona del crecimiento humana (aminoácidos 177-191) que conserva la actividad lipolítica mientras elimina los efectos del IGF-1.
Se une a los receptores beta-adrenérgicos en los adipocitos para activar la lipasa sensible a hormonas.
Farmacodinamia
Los efectos de pérdida de grasa son visibles a las 4-6 semanas.
Reducción progresiva de grasa, preservación de masa magra, sin impacto en el azúcar en sangre.
Cronología
- Semanas 1-2: Movilización inicial de grasa.
- Semanas 4-6: Reducción progresiva de grasa.
- Semanas 8-12: Efecto lipolítico máximo.
Comparaciones
- AOD-9604 — efectividad Limitada, seguridad Emergente, costo $$, Intermedia de usar
- Semaglutida — efectividad Muy alta, seguridad Buena, costo $$$, Fácil de usar
Efectos adversos
Comunes:
- Dolor en el sitio de inyección
- Náuseas leves
- Fatiga temporal
Raros:
- Dolor de cabeza
- Mareos
- Enrojecimiento
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Embarazo o lactancia
- Diabetes grave
- Hipersensibilidad conocida
- Comenzar con dosis baja (250 mcg)
- Realizar ciclos con descansos
- Monitorear la glucosa en sangre
Reference data
Specifications
- Route
- Subcutaneous
- Cycle length
- 30-60 days
FAQ
Common questions
Does AOD-9604 affect blood sugar?
No, unlike full-length HGH, it does not negatively impact blood glucose or insulin sensitivity.
What is the evidence level?
This compound is classified as Anecdotal. Evidence relies primarily on self-reported user experiences. Controlled studies are lacking.
Research
Research & sources
Current evidence for AOD-9604 is rated as Anecdotal. No controlled clinical research is available.
- 1. AOD-9604 clinical trial (2000) — DOI:10.2337/diab.49.5.149
- 2. AOD-9604 clinical trial (2000)